Ruby Gadelrab Tudor

Ruby Gadelrab Tudor has over 10 years of experience in the business industry. In 2017, they became a Mentor for Endeavor and a Advisor for InsideTracker. In 2018, they served as a Commercialization Strategy Consultant for Drawbridge Health and Agendia. In 2019, they founded and became CEO of MDisrupt, and was a Commercialization Strategy Consultant for Genomics plc and an Advisor for ixlayer. In 2020, they became a Member and Contributor for Forbes Business Council. In 2021, they became a Strategic Advisor for Eli Health.

Ruby Gadelrab Tudor attended Singularity University from 2010 to 2011, where they obtained an Executive Program in Exponential Technologies. Ruby then attended UCL from 1994 to 1997, where they obtained a BSc Hons in Molecular Biology. In November 2019, they obtained a certification in Healthcare Consumerism and Implication for Care Delivery from Coursera.

Expertise

• Genomics
• Biotech

Education

• Executive Progam Singularity University (2010 — 2011)
• BSc Hons UCL (1994 — 1997)

Companies

• Strategic Advisor Eli Health (2021)
• Member and Contributor Forbes Business Council (2020)
• CEO and Founder MDisrupt (2019)
• Commercialization Strategy Consultant Genomics plc (2019)
• Mentor Endeavor (2017)
• Founder & CEO Ruby Consulting Group (2017)
• Advisor ixlayer (2019 — 2021)
• Advisor InsideTracker (2017 — 2021)
• Commercialization Strategy Consultant Drawbridge Health (2018 — 2020)